Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study was to compare the therapeutic efficacy of clobetasol propionate 0.05% oral gel versus an anti-inflammatory mouthwash in an oral solution for the management of patients suffering from symptomatic OLP. The secondary objective was to analyze which one of the two treatments induced a greater risk of developing side effects.


Clinical Trial Description

Forty patients were assigned (20 patients per group), through a randomized design, to receive clobetasol (clobetasol gel 0.05%), or an anti-inflammatory mouthwash (mouthwash which contains calcium hydroxide, hyaluronic acid, Umbelliferone and Oligomeric Proanthocyanidins) for 3-months. At baseline (T0) and after 3 months (T1), patients were subjected to clinical and oral assessments and were evaluated for the symptoms (Numerical Pain Scale, NRS score) and signs (Thongprasom's score) of OLP. Data were calculated using T-test for the dependent variable, Wilcoxon test and Mann-Witney u test. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04673916
Study type Interventional
Source University of Messina
Contact
Status Completed
Phase N/A
Start date June 1, 2019
Completion date June 25, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03320460 - Photobiomodulation in Oral Lichen Planus N/A
Completed NCT02276573 - Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus N/A
Recruiting NCT06158113 - Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study Phase 2
Completed NCT03687437 - Lichen Planus and Mean Platelet Volum
Completed NCT00130572 - Efficacy of Elidel Cream on Erosive Oral Lichen Planus Phase 3
Not yet recruiting NCT06362005 - The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus Phase 4
Completed NCT00102557 - Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus Phase 2
Completed NCT00133107 - Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus N/A
Completed NCT04718311 - Study on Treatment for Patients With Symptomatic Oral Lichen Planus N/A
Recruiting NCT05330572 - Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
Completed NCT00656214 - Treatmant of Oral Lichen Planus With Lycopene Phase 2
Completed NCT04976673 - Comparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen Planus Phase 2
Completed NCT00746772 - Efficacy of Purslane in Treatment of Oral Lichen Planus Phase 2